Emerald Mutual Fund Advisers Trust’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-34,280
Closed -$2.84M 231
2024
Q2
$2.84M Hold
34,280
0.15% 116
2024
Q1
$2.93M Sell
34,280
-75,031
-69% -$5.89M 0.15% 117
2023
Q4
$9.35M Sell
109,311
-325
-0.3% -$28.1K 0.49% 81
2023
Q3
$9.82M Sell
109,636
-32,866
-23% -$2.93M 0.59% 77
2023
Q2
$12.1M Hold
142,502
0.66% 70
2023
Q1
$11.8M Buy
142,502
+2,880
+2% +$233K 0.7% 66
2022
Q4
$11M Sell
139,622
-126,841
-48% -$10.2M 0.68% 63
2022
Q3
$19.7M Sell
266,463
-15,430
-5% -$1.11M 1.25% 23
2022
Q2
$18.4M Buy
281,893
+60,125
+27% +$3.56M 1.06% 29
2022
Q1
$14M Buy
+221,768
New +$12.1M 0.62% 63
2020
Q3
Sell
-70,013
Closed -$6.27M 335
2020
Q2
$6.27M Sell
70,013
-165,727
-70% -$16.7M 0.3% 104
2020
Q1
$23.5M Sell
235,740
-3,500
-1% -$380K 1.47% 15
2019
Q4
$27.5M Buy
239,240
+60,263
+34% +$7.29M 1.12% 21
2019
Q3
$22.6M Buy
178,977
+12,360
+7% +$1.57M 1% 29
2019
Q2
$20.1M Buy
166,617
+21,690
+15% +$2.13M 0.8% 39
2019
Q1
$12.7M Buy
144,927
+24,500
+20% +$2.23M 0.51% 67
2018
Q4
$12M Buy
+120,427
New +$12.7M 0.56% 62

Other funds holding HAE

Emerald Mutual Fund Advisers Trust's HAE Position: Q3 2024 in Review

Emerald Mutual Fund Advisers Trust sold out of Haemonetics (HAE) in Q3 2024, closing a stake of 34,280 shares — an estimated $2.84M sold.

Emerald Mutual Fund Advisers Trust first reported a position in HAE in Q4 2018 and held it in 17 quarters. The position peaked at $27.5M in Q4 2019. 306 funds tracked by Wall St. Rank hold HAE as of Q3 2024.

  • Emerald Mutual Fund Advisers Trust reported no remaining Haemonetics position as of Q3 2024 after selling out during the quarter.
  • Emerald Mutual Fund Advisers Trust sold 34,280 Haemonetics shares in Q3 2024, an estimated $2.84M.
  • Emerald Mutual Fund Advisers Trust first reported a position in Haemonetics in Q4 2018 and held it in 17 quarters.
  • Emerald Mutual Fund Advisers Trust's Haemonetics position peaked at $27.5M in Q4 2019.
  • 306 funds tracked by Wall St. Rank held Haemonetics as of Q3 2024.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q3 2024, filed 29 Oct 2024.